Tenet Healthcare (THC)
(Delayed Data from NYSE)
$158.09 USD
-3.19 (-1.98%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $157.93 -0.16 (-0.10%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth B Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
THC 158.09 -3.19(-1.98%)
Will THC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for THC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for THC
3 Medical Stocks to Consider as Markets Take a Breather
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
THC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
ENSG's Q2 Earnings Beat on Higher Occupancy Rates, Stock Up 9%
Other News for THC
RSP: S&P 500 Monthly Dashboard For August
Decoding Tenet Healthcare Corp (THC): A Strategic SWOT Insight
Franklin Income SMA Q2 2025 Commentary
Franklin Income Fund Q2 2025 Commentary
What Does the Market Think About Tenet Healthcare?